In a report released on January 30, Rasmus Engberg from Kepler Capital maintained a Buy rating on Evolution Gaming Group AB (EVO – Research ...

BIOHIT Oyj is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic ...

The combined value of all investment products tracking the NDX® ecosystem globally exceeds $500 billion94 Exchange Traded Products track NDX® in ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

2-Year U.S. Treasury Note Continuous Contract $102.824-0.070-0.07% 5-Year U.S. Treasury Note Continuous Contract $106.383-0.234-0.22% 10-Year U.S. Treasury Note Continuous Contract $108.813-0.422 ...

Goldman Sachs downgrades MGY and OXY, reinstates coverage on EXE. MGY's outperformance reflected in current stock price, ...

HBX Group priced its initial public offering at between 10.50 euros and 12.50 euros a share, implying a market capitalization of up to $3.15 billion. The Spanish travel technology firm received ...

Goldman Sachs analyst Neil Mehta downgraded Occidental Petroleum (OXY – Research Report) to a Sell today and set a price target of $45.00. The ...